[1] |
ZHANG Chi, CHEN Jiahui, LIN Jinyi, WANG Yan, ZHANG Sijia, ZHU Wei, CHENG Leilei.
Validation of a scale for evaluating the cardiovascular risk after breast cancer therapy: the clinical scale for breast cancer treatment related cardiovascular toxicity
[J]. China Oncology, 2022, 32(1): 54-60.
|
[2] |
JIN Yizi, LIN Mingxi, ZHANG Jian.
Targeting DNA damage response deficiency in the treatment of breast cancer
[J]. China Oncology, 2022, 32(1): 61-67.
|
[3] |
Expert group of expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition) .
Expert consensus on neoadjuvant treatment of breast cancer in China (2021 edition)
[J]. China Oncology, 2022, 32(1): 80-89.
|
[4] |
LU Renquan, LIU Guangyu, YANG Wentao, GUO Lin, GUAN Ming, SHAO Zhimin, XU Dazhi, NI Ming, TANG Feng, WANG Chaofu, LOU Jiatao, SUN Fenyong, XING Jinliang, PAN Yueyin.
Application consensus of peripheral blood HER2 gene amplification detection (digital PCR) in anti-HER2 therapy
[J]. China Oncology, 2022, 32(1): 90-96.
|
[5] |
ZHANG Xiaoyan , LI Qingxiang , LIU Yong , LI Hang , QIU Lijuan , FENG Xinran , TAN Liming .
A study on the correlation between HMGB1 and clinical characteristics and immune function in patients with breast cancer
[J]. China Oncology, 2021, 31(9): 783-788.
|
[6] |
CAO Ailing, CAO Zhe, ZHOU Jian.
Effects of docetaxel combined with thymosin α1 on number of Treg in immune microenvironment of rats with breast cancer and its mechanism
[J]. China Oncology, 2021, 31(9): 799-806.
|
[7] |
YAO Jia , LI Guanqiao , YANG Shiping , SU Huiluan .
Effect of hsa-miR-98-5p/DKK3 signal axis on biological behavior of breast cancer cells
[J]. China Oncology, 2021, 31(9): 807-816.
|
[8] |
CONG Binbin, WANG Yongsheng.
Treatment landscape and challenges of managing the hormone receptor-positive early breast cancer
[J]. China Oncology, 2021, 31(8): 689-696.
|
[9] |
ZHU Yihui, LI Ting, HU Xichun.
Clinical research progress and prospect of trastuzumab deruxtecan
[J]. China Oncology, 2021, 31(8): 754-761.
|
[10] |
JIN Youping, LI Luying, ZHOU Ping.
A study on the role of long non-coding RNA STMN1P2 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(7): 596-604.
|
[11] |
XIE Jinfang , CAO Chunyu , REN Xue , TIAN Jiajun , LÜ Yafeng , HUANG Xiaofei .
Effects of sulforaphane on epithelial-mesenchymal transition, proliferation and migration of mouse breast cancer 4T1 cells
[J]. China Oncology, 2021, 31(7): 605-615.
|
[12] |
ZENG Feng , LI Dan , SHAO Xinxin , ZHANG Nengying , CHEN Xinghan , CHENG Xiaoming .
Prognostic nomogram for elderly breast cancer patients with 1-2 positive nodes who underwent mastectomy and different axillary surgeries: a SEER-based study
[J]. China Oncology, 2021, 31(4): 323-329.
|
[13] |
WANG Chunjian , NIE Gang , MAO Yan .
The role of TRIP6 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(3): 161-169.
|
[14] |
HU Xi’e , YANG Zhenyu , XUE Jingyi , YANG Ping , PENG Shujia , YUAN Lijuan , BAO Guoqiang .
Research progress of single-cell sequencing in neoadjuvant chemotherapy for triple-negative breast cancer
[J]. China Oncology, 2021, 31(3): 221-226.
|
[15] |
HOU Jing, CHENG Jigan, WANG Hua, WEI Na, NI Qing.
Preliminary study on synergistic effect of nifuroxazide and olaparib on growth inhibition in breast cancer cells
[J]. China Oncology, 2021, 31(12): 1168-1173.
|